PepGen shares are trading lower after the company reported Q4 EPS results. Also, Wedbush maintained an Outperform rating on the stock and lowered its price target from $21 to $20.
Portfolio Pulse from Benzinga Newsdesk
PepGen's stock is trading lower following the announcement of its Q4 earnings per share (EPS) results. Additionally, Wedbush has maintained an Outperform rating on PepGen but reduced its price target from $21 to $20.
March 07, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
PepGen's shares have declined following its Q4 EPS report, with Wedbush maintaining an Outperform rating but lowering the price target from $21 to $20.
The decline in PepGen's stock price is directly related to its Q4 EPS results, indicating investor disappointment or concern. Wedbush's decision to maintain an Outperform rating yet lower the price target suggests a positive outlook with adjusted expectations, which could influence investor sentiment and stock performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100